Dafna-Capital-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "ASND",
  "EWTX",
  "ALKS",
  "RVMD",
  "ORIC",
  "GLPG",
  "BCAX",
  "BCYC",
  "ATXS",
  "ALLO",
  "RCUS",
  "GPCR",
  "IMTX",
  "TSHA",
  "ACET",
  "STOK",
  "LRMR",
  "MLYS",
  "ADCT",
  "SNDX",
  "KROS",
  "NGNE",
  "SAGE",
  "TSVT",
  "ALEC",
  "APRE",
  "BWAY",
  "PHGE",
  "AUTL",
  "NBIX",
  "KRRO",
  "KALV",
  "LXEO",
  "LCTX",
  "MDWD",
  null,
  "PVLA",
  "PRQR",
  "SPRO",
  "TELA",
  "STXS",
  "TNYA",
  "STRO",
  null,
  "IFRX",
  "PODD",
  "IDYA",
  null,
  "SPRY",
  null,
  "ATRC",
  "AQST",
  "RGLS",
  "ARAY",
  "GOSS",
  "ALGN",
  "CGEN",
  "CMPS",
  "ERAS",
  "ITOS",
  "INGN",
  "KURA",
  "URGN",
  "VKTX",
  "VYNE",
  "XENE",
  "FHTX",
  "BHVN",
  "TNDM",
  "IMVT",
  null,
  "AXGN",
  "BDTX",
  "BCRX",
  "BNTX",
  "BPMC",
  "CRDF",
  "IPSC",
  "DAWN",
  "CYTK",
  "DNLI",
  "DXCM"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 83
Total Value: 352661806
Accession Number: 0001389933-25-000002
Form Type: 13F-HR
CIK: dafna-capital-management
Manager Name: Dafna-Capital-Management

Data Enrichment

94% identified

78 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

83 positions • $352.7M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 3 of 5

Sort by:

Denali Therapeutics Inc.

DNLI|24823R105

Shares:127.9K

Value:$1.7M

% of Portfolio:0.5% ($1.7M/$352.7M)

Astria Therapeutics, Inc.

ATXS|04635X102

Shares:314.8K

Value:$1.7M

% of Portfolio:0.5% ($1.7M/$352.7M)

Viking Therapeutics, Inc.

VKTX|92686J106

Shares:64.5K

Value:$1.6M

% of Portfolio:0.4% ($1.6M/$352.7M)

Regulus Therapeutics Inc.

RGLS|75915K309

Shares:847.2K

Value:$1.5M

% of Portfolio:0.4% ($1.5M/$352.7M)

Brainsway Ltd.

BWAY|10501L106

Shares:156.5K

Value:$1.5M

% of Portfolio:0.4% ($1.5M/$352.7M)

Oric Pharmaceuticals, Inc.

ORIC|68622P109

Shares:242.0K

Value:$1.4M

% of Portfolio:0.4% ($1.4M/$352.7M)

Keros Therapeutics, Inc.

KROS|492327101

Shares:130.3K

Value:$1.3M

% of Portfolio:0.4% ($1.3M/$352.7M)

Lexeo Therapeutics, Inc.

LXEO|52886X107

Shares:378.1K

Value:$1.3M

% of Portfolio:0.4% ($1.3M/$352.7M)

iTeos Therapeutics, Inc.

ITOS|46565G104

Shares:213.3K

Value:$1.3M

% of Portfolio:0.4% ($1.3M/$352.7M)

PALVELLA THERAPEUTICS, INC.

PVLA|697947109

Shares:43.3K

Value:$1.2M

% of Portfolio:0.3% ($1.2M/$352.7M)

ARS Pharmaceuticals, Inc.

SPRY|82835W108

Shares:95.3K

Value:$1.2M

% of Portfolio:0.3% ($1.2M/$352.7M)

Lineage Cell Therapeutics, Inc.

LCTX|53566P109

Shares:2.5M

Value:$1.1M

% of Portfolio:0.3% ($1.1M/$352.7M)

Alector, Inc.

ALEC|014442107

Shares:912.9K

Value:$1.1M

% of Portfolio:0.3% ($1.1M/$352.7M)

Foghorn Therapeutics Inc.

FHTX|344174107

Shares:304.8K

Value:$1.1M

% of Portfolio:0.3% ($1.1M/$352.7M)

Immatics N.V.

IMTX|N44445109

Shares:245.0K

Value:$1.1M

% of Portfolio:0.3% ($1.1M/$352.7M)

Structure Therapeutics Inc.

GPCR|86366E106

Shares:59.0K

Value:$1.0M

% of Portfolio:0.3% ($1.0M/$352.7M)

VYNE Therapeutics Inc.

VYNE|92941V308

Shares:636.1K

Value:$1.0M

% of Portfolio:0.3% ($1.0M/$352.7M)

MediWound Ltd.

MDWD|M68830112

Shares:64.5K

Value:$1.0M

% of Portfolio:0.3% ($1.0M/$352.7M)

Gossamer Bio, Inc.

GOSS|38341P102

Shares:907.9K

Value:$998.6K

% of Portfolio:0.3% ($998.6K/$352.7M)

BioNTech SE

BNTX|09075V102

Shares:10.5K

Value:$956.1K

% of Portfolio:0.3% ($956.1K/$352.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Denali Therapeutics Inc.(DNLIcusip24823R105)	127.9K	QoQ NEW(+127.9K) YoY NEW(+127.9K)	All Managers (Combined)	$1.7M	0.5% ($1.7M/$352.7M)	QoQ NEW(+$1.7M) YoY NEW(+$1.7M)
Astria Therapeutics, Inc.(ATXScusip04635X102)	314.8K	QoQ +5.00% (-15.0K) YoY +40.98% (-91.5K)	All Managers (Combined)	$1.7M	0.5% ($1.7M/$352.7M)	QoQ -37.27% (-$999.1K) YoY -46.51% (-$1.5M)
Viking Therapeutics, Inc.(VKTXcusip92686J106)	64.5K	QoQ 0.00% (-0) YoY -66.76% (-129.6K)	All Managers (Combined)	$1.6M	0.4% ($1.6M/$352.7M)	QoQ -39.98% (-$1.0M) YoY -90.21% (-$14.4M)
Regulus Therapeutics Inc.(RGLScusip75915K309)	847.2K	QoQ -3.20% (-28.0K) YoY -20.86% (-223.4K)	All Managers (Combined)	$1.5M	0.4% ($1.5M/$352.7M)	QoQ +7.21% (-$99.7K) YoY -51.91% (-$1.6M)
Brainsway Ltd.(BWAYcusip10501L106)	156.5K	QoQ -18.98% (-36.7K) YoY -47.41% (-141.1K)	All Managers (Combined)	$1.5M	0.4% ($1.5M/$352.7M)	QoQ -18.63% (-$339.6K) YoY -5.85% (-$92.2K)
Oric Pharmaceuticals, Inc.(ORICcusip68622P109)	242.0K	QoQ NEW(+242.0K) YoY NEW(+242.0K)	All Managers (Combined)	$1.4M	0.4% ($1.4M/$352.7M)	QoQ NEW(+$1.4M) YoY NEW(+$1.4M)
Keros Therapeutics, Inc.(KROScusip492327101)	130.3K	QoQ 0.00% (-0) YoY +92.33% (-62.6K)	All Managers (Combined)	$1.3M	0.4% ($1.3M/$352.7M)	QoQ -35.62% (-$735.0K) YoY -70.39% (-$3.2M)
Lexeo Therapeutics, Inc.(LXEOcusip52886X107)	378.1K	QoQ -3.81% (-15.0K) YoY NEW(+378.1K)	All Managers (Combined)	$1.3M	0.4% ($1.3M/$352.7M)	QoQ -49.27% (-$1.3M) YoY NEW(+$1.3M)
iTeos Therapeutics, Inc.(ITOScusip46565G104)	213.3K	QoQ +13.27% (-25.0K) YoY +116.46% (-114.8K)	All Managers (Combined)	$1.3M	0.4% ($1.3M/$352.7M)	QoQ -11.94% (-$172.8K) YoY -5.25% (-$70.7K)
PALVELLA THERAPEUTICS, INC.(PVLAcusip697947109)	43.3K	QoQ -39.33% (-28.1K) YoY NEW(+43.3K)	All Managers (Combined)	$1.2M	0.3% ($1.2M/$352.7M)	QoQ +41.50% (-$355.9K) YoY NEW(+$1.2M)
ARS Pharmaceuticals, Inc.(SPRYcusip82835W108)	95.3K	QoQ +7.32% (+6.5K) YoY -60.16% (-143.9K)	All Managers (Combined)	$1.2M	0.3% ($1.2M/$352.7M)	QoQ +27.97% (+$262.0K) YoY -50.96% (-$1.2M)
Lineage Cell Therapeutics, Inc.(LCTXcusip53566P109)	2.5M	QoQ 0.00% (-0) YoY +83.80% (-1.1M)	All Managers (Combined)	$1.1M	0.3% ($1.1M/$352.7M)	QoQ -10.12% (-$127.8K) YoY -43.91% (-$888.0K)
Alector, Inc.(ALECcusip014442107)	912.9K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.1M	0.3% ($1.1M/$352.7M)	QoQ -34.92% (-$602.5K) YoY -79.56% (-$4.4M)
Foghorn Therapeutics Inc.(FHTXcusip344174107)	304.8K	QoQ +63.21% (+118.0K) YoY NEW(+304.8K)	All Managers (Combined)	$1.1M	0.3% ($1.1M/$352.7M)	QoQ +26.21% (+$231.0K) YoY NEW(+$1.1M)
Immatics N.V.(IMTXcusipN44445109)	245.0K	QoQ 0.00% (-0) YoY +68.96% (-100.0K)	All Managers (Combined)	$1.1M	0.3% ($1.1M/$352.7M)	QoQ -36.56% (-$637.0K) YoY -27.49% (-$419.0K)
Structure Therapeutics Inc.(GPCRcusip86366E106)	59.0K	QoQ +66.19% (+23.5K) YoY NEW(+59.0K)	All Managers (Combined)	$1.0M	0.3% ($1.0M/$352.7M)	QoQ +6.07% (+$58.5K) YoY NEW(+$1.0M)
VYNE Therapeutics Inc.(VYNEcusip92941V308)	636.1K	QoQ NEW(+636.1K) YoY NEW(+636.1K)	All Managers (Combined)	$1.0M	0.3% ($1.0M/$352.7M)	QoQ NEW(+$1.0M) YoY NEW(+$1.0M)
MediWound Ltd.(MDWDcusipM68830112)	64.5K	QoQ 0.00% (-0) YoY -65.83% (-124.3K)	All Managers (Combined)	$1.0M	0.3% ($1.0M/$352.7M)	QoQ -12.80% (-$147.0K) YoY -62.79% (-$1.7M)
Gossamer Bio, Inc.(GOSScusip38341P102)	907.9K	QoQ -35.57% (-501.4K) YoY -35.57% (-501.4K)	All Managers (Combined)	$998.6K	0.3% ($998.6K/$352.7M)	QoQ -21.66% (-$276.2K) YoY -39.94% (-$664.3K)
BioNTech SE(BNTXcusip09075V102)	10.5K	QoQ +23.52% (-2.0K) YoY -38.23% (-6.5K)	All Managers (Combined)	$956.1K	0.3% ($956.1K/$352.7M)	QoQ -1.28% (-$12.4K) YoY -39.03% (-$612.1K)